Margin Notes: New Wrappers, Old Leverage

This week's reads kept circling one question. When someone builds a new wrapper that gives ordinary investors access to something, what else rides along in the package? One piece shows what happened when leveraged single-stock products met a strong story. A regulator shipped a cousin of that...

Read More →

Margin Notes: Scarce Compute, Cheap Tokens

This week's reads made two claims that sound like they contradict each other. One says AI compute will stay short of demand through 2028. Another says Opus-class work now costs about a tenth of what it did. Both can be true at once. When they are, the margin moves to new owners, and these pieces...

Read More →

Margin Notes: The Build-Out Meets the Ballot Box

This week's reads contradicted each other in a useful way. The October jobs data says the AI build-out is now carrying a visible share of US manufacturing employment. Election night says voters in a lot of places would like less of it. Meanwhile, the biggest AI company to file for an IPO is asking...

Read More →

Margin Notes: Diversification That Turns Out to Be One Bet

Across this week's reads, positions that look like separate bets kept turning out to be the same bet. AI lab equity, hyperscaler credit, emerging-market earnings, and even "global" bond yields all trace back to one or two underlying drivers. The pieces disagree about whether that is a mania or a...

Read More →

Margin Notes: Healthy Averages, One Load-Bearing Beam

Every aggregate I read this week said "fine." The S&P 500 is up double digits, GDP held up through a tariff shock, and AI hasn't dented employment. But each time I opened up the aggregate, the same beam was holding it up: the AI buildout. So the question for this issue is whether we're looking at...

Read More →

Margin Notes: A Narrow Expansion and a Nervous Bond Market

Two smart readers looked at this expansion this week and came away with different confidence levels. One measured how narrow U.S. growth has become and called it fragile. The other finances that growth for a living and puts the odds of it continuing at 85%. Between them sits a bond market charging...

Read More →

Margin Notes: The Number Moved, the Risk Didn't

This week's reads share one question: when a headline number improves, did the risk shrink or just change address? Tariff inflation fades while prices stay high. A bank's capital ratio rises while its parent's doesn't. The "riskless" anchor in valuation is now an adjusted estimate. I kept finding...

Read More →

Margin Notes: What an ANT Buyer Is Actually Underwriting

Anthropic filed its S-1 this week, and everything else I read seemed to be arguing about it. I came away with one question: what exactly is the buyer of this stock paying for? Damodaran says it's a single revenue assumption. Noah Smith says it's a moat that may not exist. Azeem Azhar says the value...

Read More →

Margin Notes: Priced, Not Valued

Damodaran spent the month on the difference between pricing a company and valuing one. Once I had that lens, I kept finding the same gap elsewhere. One AI lab's revenue jitters are moving Treasuries more than CPI. Index-level earnings look heroic while the median household goes backward. The...

Read More →

Margin Notes: Who Ends Up Holding the AI Capex Bill

Nobody in my reading pile disputes that the AI build-out is enormous. They disagree about who pays for it. Ritholtz and Scanlon say you can already see the bill in bond yields. Damodaran says it is accumulating in private credit. Visser argues the whole "debt endgame" frame keeps failing because it...

Read More →